Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index; 36 of the 45 sources its claims cite were checked for support.

Proteotoxic stress response drives T cell exhaustion and immune evasion

Open access

Abstract

Chronic infections and cancer cause T cell dysfunction known as exhaustion. This cell state is caused by persistent antigen exposure, suboptimal co-stimulation and a plethora of hostile factors that dampen protective immunity and limit the efficacy of immunotherapies1–4. The mechanisms that underlie T cell exhaustion remain poorly understood. Here we analyse the proteome of CD8+ exhausted T (Tex) cells across multiple states of exhaustion in the context of both chronic viral infections and cancer. We show that there is a non-stochastic pathway-specific discordance between mRNA and protein dynamics between T effector (Teff) and Tex cells. We identify a distinct proteotoxic stress response (PSR) in Tex cells, which we term Tex-PSR. Contrary to canonical stress responses that induce a reduction in protein synthesis5,6, Tex-PSR involves an increase in global translation activity and an upregulation of specialized chaperone proteins. Tex-PSR is further characterized by the accumulation of protein aggregates and stress granules and an increase in autophagy-dominant protein catabolism. We establish that disruption of proteostasis alone can convert Teff cells to Tex cells, and we link Tex-PSR mechanistically to persistent AKT signalling. Finally, disruption of Tex-PSR-associated chaperones in CD8+ T cells improves cancer immunotherapy in preclinical models. Moreover, a high Tex-PSR in T cells from patients with cancer confers poor responses to clinical immunotherapy. Collectively, our findings indicate that Tex-PSR is a hallmark and a mechanistic driver of T cell exhaustion, which raises the possibility of targeting proteostasis pathways as an approach for cancer immunotherapy. A proteotoxic stress response specific to exhausted T cells, governed by AKT signaling and accompanied by increased protein translation, represents a mechanistic vulnerability and a new therapeutic target to improve cancer immunotherapies.

Overview

CoChat Summary

TL;DR

This paper identifies a distinct proteotoxic stress response in exhausted CD8+ T cells, termed Tex-PSR, that features increased global translation, chaperone upregulation, protein aggregation, and autophagy-dominant catabolism rather than the translation shutdown seen in canonical stress responses. The authors link Tex-PSR to sustained AKT signaling, show that inducing proteostasis defects can drive exhaustion, and report that disrupting Tex-PSR chaperones improves anti-tumor immunity in preclinical models.

Key findings

  • Across in vitro exhaustion, chronic LCMV infection, and mouse tumor models, Tex cells showed pathway-specific discordance between RNA and protein levels; overall mRNA–protein correlations were weak, with Pearson’s coefficients of 0.31 in Teff cells and 0.38 in Tex cells.
  • Tex cells had increased protein synthesis: HPG labeling showed higher translation in Tex cells than acutely stimulated Teff cells, and in MC38 tumors Ttex cells had higher OPP incorporation than Tprog and Tint cells.
  • Protein aggregation was widespread in Tex cells: native proteomics detected 3,889 proteins, and 2,878 (74%) shifted from low- to high-molecular-weight species in Tex cells; granzyme B, granzyme C, perforin, and gp96 were among aggregated proteins.
  • Sustained AKT signaling drove Tex-PSR: AKT phosphorylation was elevated in Tex cells, MK2206 partially reversed exhaustion, and constitutively active myrAKT converted Teff cells into Tex-like cells and impaired tumor control.
  • Disrupting chaperones improved function: deleting Hspa5, Hsp90b1, or Ero1a increased cytokine production, and Hsp90b1 deletion expanded total and antigen-specific CD8+ T cells during chronic LCMV infection; Hspa5 or Ero1a knockout P14 cells improved control of gp33-expressing MB49 tumors.
  • In human cancer datasets, a higher Tex-PSR signature in CD8+ T cells was associated with poor overall survival in liver cancer and with poor responses to immunotherapies, including CAR T cells and checkpoint blockade.

Methods

  • The study combined an in vitro repeated-TCR-stimulation exhaustion model with in vivo chronic LCMV infection, MC38 colon tumor, MB49 bladder tumor, and adoptive cell transfer models in mice, plus analyses of public human single-cell RNA-seq datasets.
  • The main assays were quantitative proteomics by mass spectrometry, bulk RNA-seq, flow cytometry, protein aggregation/stress granule staining, CRISPR–Cas9 gene editing, and functional tumor-control or infection readouts.
  • Human relevance was assessed using pan-cancer scRNA-seq data from 346 tumor samples from 251 individuals across 20 datasets, and survival/immunotherapy-response analyses in liver cancer and treated patient cohorts.

Limitations

  • The paper does not provide, in the text shown here, a single integrated numerical effect size for the preclinical tumor-therapy improvements beyond stating that control was “significantly better” or that responses were poorer/better; details are mainly described per figure.
  • Evident from the text: several human findings rely on publicly available scRNA-seq datasets and retrospective survival/response analyses, so the clinical associations are correlative rather than causal.
  • Not stated in the paper.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41586-025-09539-1

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 PSR is triggered in Tex cells with a dynamic expression of chaperone proteins. a, Schematic of the experiment to isolate mouse splenic LCMV antigen-specific CD8+ T cell subpopulations in LCMV acute (Armstrong (Arm)) and chronic (clone 13 (Cl13)) infection models. b, Heatmap of expression levels of proteins belonging to 11 T cell signatures across 9 groups (n = 3–4, representing pooled 5–15 mice per replicate). D, day. c, Heatmap of the expression profiles of 5,284 proteins quantified in naive T cells, acutely activated T cells (Teff) and chronically activated T cells (Tex) at 2, 4, 6 and 8 days after initial activation, as described in Extended Data Fig. 1a, with k-means clustering identifying 8 distinct expression patterns (n = 4, each replicate was pooled from 3 mice). d, Enrichment analysis of proteins from cluster 6 defined in c (one-sided Fisher’s exact test with Benjamini–Hochberg correction). e, Heatmap of expression levels of proteins belonging to 12 gene ontology terms. f, Schematic of MS-based proteomic analysis of CD8+ T cells in different exhaustion states from the MC38 colon cancer mouse model and the MB49 bladder tumour mouse model. s.c., subcutaneous. g, Principal component analysis plots of proteomes of Tprog, Tint and Ttex cells (n = 3, each biological replicate was pooled from 12–13 mice). h, Heatmap of protein expression across eight gene ontologies in three CD8+ T cell subpopulations from MC38 and MB49 tumour models. i, Bubble plot of the expression levels of protein-folding chaperones in naive, Teff and Tex CD8+ T cells generated in vitro as described in Extended Data Fig. 1a. The bubble colour intensity is proportional to the protein expression level. The bubble size is proportional to the absolute z score value. j, Heatmap of the expression levels of chaperone proteins (defined in i) in three CD8+ T cell subpopulations from MC38 and MB49 tumours. The diagrams in a and f were created using BioRender (https://www.biorender.com).
Fig. 1 PSR is triggered in Tex cells with a dynamic expression of chaperone proteins. a, Schematic of the experiment to isolate mouse splenic LCMV antigen-specific CD8+ T cell subpopulations in LCMV acute (Armstrong (Arm)) and chronic (clone 13 (Cl13)) infection models. b, Heatmap of expression levels of proteins belonging to 11 T cell signatures across 9 groups (n = 3–4, representing pooled 5–15 mice per replicate). D, day. c, Heatmap of the expression profiles of 5,284 proteins quantified in naive T cells, acutely activated T cells (Teff) and chronically activated T cells (Tex) at 2, 4, 6 and 8 days after initial activation, as described in Extended Data Fig. 1a, with k-means clustering identifying 8 distinct expression patterns (n = 4, each replicate was pooled from 3 mice). d, Enrichment analysis of proteins from cluster 6 defined in c (one-sided Fisher’s exact test with Benjamini–Hochberg correction). e, Heatmap of expression levels of proteins belonging to 12 gene ontology terms. f, Schematic of MS-based proteomic analysis of CD8+ T cells in different exhaustion states from the MC38 colon cancer mouse model and the MB49 bladder tumour mouse model. s.c., subcutaneous. g, Principal component analysis plots of proteomes of Tprog, Tint and Ttex cells (n = 3, each biological replicate was pooled from 12–13 mice). h, Heatmap of protein expression across eight gene ontologies in three CD8+ T cell subpopulations from MC38 and MB49 tumour models. i, Bubble plot of the expression levels of protein-folding chaperones in naive, Teff and Tex CD8+ T cells generated in vitro as described in Extended Data Fig. 1a. The bubble colour intensity is proportional to the protein expression level. The bubble size is proportional to the absolute z score value. j, Heatmap of the expression levels of chaperone proteins (defined in i) in three CD8+ T cell subpopulations from MC38 and MB49 tumours. The diagrams in a and f were created using BioRender (https://www.biorender.com).CC BY-NC-ND · PubMed Central
Fig. 2 Chronic TCR stimulation disrupts proteostasis during T cell exhaustion. a, ImageStream analysis of protein aggregates in Teff and Tex cells 8 days after initial activation in vitro. Numbers are identifiers of representative cells within the samples. Scale bar, 7 µm. b, Flow cytometry quantification of protein aggregates (n = 8 for Teff and n = 7 for Tex, two-tailed t-test). MFI, mean fluorescence intensity. c,d, Protein aggregates in CD8+ T cell subpopulations from mouse MC38 tumours (c) and MB49 tumours (d) (n = 4 for spleens, n = 7 for TILs, one-way analysis of variance (ANOVA)). e, Flow cytometry histogram and bar plot of HPG incorporation in Teff and Tex cells in vitro (n = 4, two-tailed t-test). f, Flow cytometry histogram and bar plot of OPP incorporation in CD8+ T cell subpopulations from mouse MC38 tumours (n = 7, one-way ANOVA). g, Schematic of native PAGE and determination of the proteome by MS. Teff and Tex cells were generated as described in Extended Data Fig. 4d. h, Heatmap showing the fold change of 3,889 proteins in HMW and LMW species. i, Lack of association between aggregation tendency of proteins and their functional pathways. Bar colours depict the migration pattern of proteins as indicated in h. j, Fold changes of indicated protein abundances in HMW and LMW species. k, Schematic of cell lysate fractionation based on protein solubility. l, Immunoblot analysis of granzyme B (GZMB), perforin, gp96 and HSP90α in the soluble fractions of cell lysates separated by native PAGE. m, Immunoblot analysis of the indicated proteins in soluble fractions separated by SDS–PAGE. n, Immunoblot analysis of the indicated proteins in insoluble fractions resolved by SDS–PAGE. For l–n, the values on the left of the blots are kDa. For immunoblot source data, see Supplementary Fig. 1. Data in h–j are representative of two independent experiments. Experiments in l–n were repeated at least three times. Data are presented as the mean ± s.d. (b–f). The diagrams in g and k were created using BioRender (https://www.biorender.com). Source Data
Fig. 2 Chronic TCR stimulation disrupts proteostasis during T cell exhaustion. a, ImageStream analysis of protein aggregates in Teff and Tex cells 8 days after initial activation in vitro. Numbers are identifiers of representative cells within the samples. Scale bar, 7 µm. b, Flow cytometry quantification of protein aggregates (n = 8 for Teff and n = 7 for Tex, two-tailed t-test). MFI, mean fluorescence intensity. c,d, Protein aggregates in CD8+ T cell subpopulations from mouse MC38 tumours (c) and MB49 tumours (d) (n = 4 for spleens, n = 7 for TILs, one-way analysis of variance (ANOVA)). e, Flow cytometry histogram and bar plot of HPG incorporation in Teff and Tex cells in vitro (n = 4, two-tailed t-test). f, Flow cytometry histogram and bar plot of OPP incorporation in CD8+ T cell subpopulations from mouse MC38 tumours (n = 7, one-way ANOVA). g, Schematic of native PAGE and determination of the proteome by MS. Teff and Tex cells were generated as described in Extended Data Fig. 4d. h, Heatmap showing the fold change of 3,889 proteins in HMW and LMW species. i, Lack of association between aggregation tendency of proteins and their functional pathways. Bar colours depict the migration pattern of proteins as indicated in h. j, Fold changes of indicated protein abundances in HMW and LMW species. k, Schematic of cell lysate fractionation based on protein solubility. l, Immunoblot analysis of granzyme B (GZMB), perforin, gp96 and HSP90α in the soluble fractions of cell lysates separated by native PAGE. m, Immunoblot analysis of the indicated proteins in soluble fractions separated by SDS–PAGE. n, Immunoblot analysis of the indicated proteins in insoluble fractions resolved by SDS–PAGE. For l–n, the values on the left of the blots are kDa. For immunoblot source data, see Supplementary Fig. 1. Data in h–j are representative of two independent experiments. Experiments in l–n were repeated at least three times. Data are presented as the mean ± s.d. (b–f). The diagrams in g and k were created using BioRender (https://www.biorender.com). Source DataCC BY-NC-ND · PubMed Central
Fig. 3 Protein misfolding promotes T cell exhaustion without chronic TCR stimulation. a, Structure of l-proline and its analogue AZC. b–d, Mouse Teff cells were treated with AZC for 6 days in vitro 2 days after optimal activation. b, Confocal imaging analysis (left) and quantification (right) of protein aggregates (n = 8, two-tailed t-test. Experiments were repeated at least 3 times). Scale bars, 5 μm. c, Percentages of PD1+TIM3+ cells out of the total live CD8+ T cells (n = 4, two-tailed t-test). d, Percentages of IFNγ+TNF+ cells over the total live CD8+ T cells (n = 4, two-tailed t-test). e, Schematic of adoptive transfer of AZC-pulsed or vehicle-pulsed OT-1 cells into Rag2–/– mice with B16-OVA tumours. NT, no transfer. f, Absolute number of tumour-infiltrating OT-1 CD8+ T cells normalized by tumour weight (n = 6 for NT and n = 7 for vehicle and AZC, one-way ANOVA). g, Percentages of SLAMF6+TIM3– and SLAMF6–TIM3+ tumour-infiltrating OT-1 cells (n = 7, two-tailed t-test). h, Schematic of introducing a model aggregation-prone protein, CFTR(ΔF508), into Teff cells by retrovirus transduction. i, Confocal imaging analysis of CFTR expression in cells transduced with CFTR(ΔF508) or empty vector (EV). Scale bars, 5 µm. j, Percentages of PD1+TIM3+ cells over total mouse CD8+ T cells transduced with CFTR(ΔF508) or EV (n = 4 for EV and n = 6 for CFTR(ΔF508), two-tailed t-test). k, Percentages of CD39+ cells out of the total transduced human CD8+ T cells 10 days after transduction (n = 3, two-tailed t-test. Experiments were repeated 3 times with cells from different donors with similar results). Data are presented as the mean ± s.d. (b–d,f,g,j,k). The diagrams in e and h were created using BioRender (https://www.biorender.com). Source Data
Fig. 3 Protein misfolding promotes T cell exhaustion without chronic TCR stimulation. a, Structure of l-proline and its analogue AZC. b–d, Mouse Teff cells were treated with AZC for 6 days in vitro 2 days after optimal activation. b, Confocal imaging analysis (left) and quantification (right) of protein aggregates (n = 8, two-tailed t-test. Experiments were repeated at least 3 times). Scale bars, 5 μm. c, Percentages of PD1+TIM3+ cells out of the total live CD8+ T cells (n = 4, two-tailed t-test). d, Percentages of IFNγ+TNF+ cells over the total live CD8+ T cells (n = 4, two-tailed t-test). e, Schematic of adoptive transfer of AZC-pulsed or vehicle-pulsed OT-1 cells into Rag2–/– mice with B16-OVA tumours. NT, no transfer. f, Absolute number of tumour-infiltrating OT-1 CD8+ T cells normalized by tumour weight (n = 6 for NT and n = 7 for vehicle and AZC, one-way ANOVA). g, Percentages of SLAMF6+TIM3– and SLAMF6–TIM3+ tumour-infiltrating OT-1 cells (n = 7, two-tailed t-test). h, Schematic of introducing a model aggregation-prone protein, CFTR(ΔF508), into Teff cells by retrovirus transduction. i, Confocal imaging analysis of CFTR expression in cells transduced with CFTR(ΔF508) or empty vector (EV). Scale bars, 5 µm. j, Percentages of PD1+TIM3+ cells over total mouse CD8+ T cells transduced with CFTR(ΔF508) or EV (n = 4 for EV and n = 6 for CFTR(ΔF508), two-tailed t-test). k, Percentages of CD39+ cells out of the total transduced human CD8+ T cells 10 days after transduction (n = 3, two-tailed t-test. Experiments were repeated 3 times with cells from different donors with similar results). Data are presented as the mean ± s.d. (b–d,f,g,j,k). The diagrams in e and h were created using BioRender (https://www.biorender.com). Source DataCC BY-NC-ND · PubMed Central
Fig. 4 Sustained AKT signalling induces Tex-PSR and underlies T cell exhaustion. a, Expression levels of proteins in major signalling pathways in Teff and Tex cells in vitro as described in Extended Data Fig. 4d. b, Levels of phosphorylated AKT (pAKT(Ser473)) in mouse Teff and Tex cells in vitro (n = 3). c, pAKT staining in splenic CD8+ T cells and TIL subsets from MC38 tumours (n = 3 for spleen, n = 6 for TILs, one-way ANOVA). d, Percentages of SLAMF6+TIM3– cells in T cells treated with chronic TCR stimulation together with MK2206 or dimethyl sulfoxide (DMSO) for 6 days (n = 4). e, Percentages of IFNγ+TNF+ cells after re-stimulation in T cells treated as in d and rested for 2 days (n = 4). f, Quantification of HPG incorporation in T cells treated as in d (n = 4). g, Quantification of protein aggregation in T cells treated as in d (n = 4). h, gp96 expression in Tex cells treated with MK2206 for 2 days (n = 3). i, Schematic of packaging MSCV-GFP (pMIG) retrovirus expressing myrAKT for T cell transduction, and the flow cytometry quantification of pAKT(Ser473) in mouse T cells transduced with myrAKT or EV (n = 3 for EV, n = 4 for myrAKT). j–m, Quantification of SLAMF6–TIM3+ cells (j), HPG incorporation (k), protein aggregation by live-cell imaging (l) and gp96 expression (m) in T cells transduced with myrAKT or EV (n = 4 (j,k,m) or n = 9 (l) per group). n, Tumour growth curves (two-way ANOVA). OT-1 cells transduced with myrAKT or EV were transferred into Rag2–/– mice with B16-OVA tumours. o, Percentages and absolute number of OT-1 T cells transduced with myrAKT or EV from tumours 5 days after adoptive cell transfer (ACT) (n = 7). p, Percentages of SLAMF6+TIM3– and SLAMF6–TIM3+ OT-1 cells from tumours (n = 7). Two-tailed t-test for comparisons between two groups. Data are the mean ± s.d. (b–m,o,p) or the mean ± s.e.m. (n). The diagram in i was created using BioRender (https://www.biorender.com). Source Data
Fig. 4 Sustained AKT signalling induces Tex-PSR and underlies T cell exhaustion. a, Expression levels of proteins in major signalling pathways in Teff and Tex cells in vitro as described in Extended Data Fig. 4d. b, Levels of phosphorylated AKT (pAKT(Ser473)) in mouse Teff and Tex cells in vitro (n = 3). c, pAKT staining in splenic CD8+ T cells and TIL subsets from MC38 tumours (n = 3 for spleen, n = 6 for TILs, one-way ANOVA). d, Percentages of SLAMF6+TIM3– cells in T cells treated with chronic TCR stimulation together with MK2206 or dimethyl sulfoxide (DMSO) for 6 days (n = 4). e, Percentages of IFNγ+TNF+ cells after re-stimulation in T cells treated as in d and rested for 2 days (n = 4). f, Quantification of HPG incorporation in T cells treated as in d (n = 4). g, Quantification of protein aggregation in T cells treated as in d (n = 4). h, gp96 expression in Tex cells treated with MK2206 for 2 days (n = 3). i, Schematic of packaging MSCV-GFP (pMIG) retrovirus expressing myrAKT for T cell transduction, and the flow cytometry quantification of pAKT(Ser473) in mouse T cells transduced with myrAKT or EV (n = 3 for EV, n = 4 for myrAKT). j–m, Quantification of SLAMF6–TIM3+ cells (j), HPG incorporation (k), protein aggregation by live-cell imaging (l) and gp96 expression (m) in T cells transduced with myrAKT or EV (n = 4 (j,k,m) or n = 9 (l) per group). n, Tumour growth curves (two-way ANOVA). OT-1 cells transduced with myrAKT or EV were transferred into Rag2–/– mice with B16-OVA tumours. o, Percentages and absolute number of OT-1 T cells transduced with myrAKT or EV from tumours 5 days after adoptive cell transfer (ACT) (n = 7). p, Percentages of SLAMF6+TIM3– and SLAMF6–TIM3+ OT-1 cells from tumours (n = 7). Two-tailed t-test for comparisons between two groups. Data are the mean ± s.d. (b–m,o,p) or the mean ± s.e.m. (n). The diagram in i was created using BioRender (https://www.biorender.com). Source DataCC BY-NC-ND · PubMed Central
Fig. 5 Targeting Tex-PSR chaperones prevents T cell exhaustion and enhances cancer immunotherapy. a, Frequencies of IFNγ+TNF+ cells (n = 3, one-way ANOVA) in cells with indicated genes knocked out. b, Quantification of protein aggregation by flow cytometry (n = 4, one-way ANOVA). c, Experimental scheme of using CD8+ T cell-specific deletion of Hsp90b1 in mice infected with LCMV clone 13. d, gp96 expression in total splenic CD8+ T cells (n = 8 for WT, n = 3 for Het, n = 5 for KO, one-way ANOVA). e, Frequencies of total CD8+ (left) and gp33-specific and gp276-specific (Tet+) CD8+ T cells (right) in spleens 30 days after infection (n = 8 for WT, n = 3 for Het, n = 5 for KO, one-way ANOVA). f, Uniform manifold approximation and projection (UMAP) of Tet+ CD8+ T cells profiled by 25-marker multispectral flow cytometry. g, Expression of selected markers mapped on UMAP. h,i, Representative flow cytometry (h) and quantification (i) of TCF1+CX3CR1–, CX3CR1+ and TCF1–CX3CR1– cells (n = 8 for WT, n = 3 for Het, n = 5 for KO, one-way ANOVA). j, Schematic of ACT using Hspa5 KO, Ero1a KO or control cells. k, Tumour growth curves (n = 4 for NT, n = 5 for the other groups, two-way ANOVA). l, Kaplan–Meier survival curves (n = 4 for NT, n = 5 for the other groups, Mantel–Cox test). Results represent three independent experiments. m,n, Representative flow cytometry plots (left) and quantification (right) of CX3CR1+ percentages (m) and TCF1 expression (n) in tumour-infiltrating P14 T cells 6 days after ACT (n = 8, two-tailed t-test). o, Tex-PSR scores in scRNA-seq CD8+ T cells from non-responders (NR) and responders (R) to anti-CD19 CAR T cell therapy for diffuse large B cell lymphoma61 (left, NR: n = 63,482 cells from 57 patients; R: n = 59,351 cells from 52 patients) and anti-PD1 therapy for non-small cell lung cancer62 and renal cell carcinoma (RCC)63 (right, NR: n = 5,672 cells from 6 patients, R: n = 37,884 cells from 18 patients). Two-sided Wilcoxon rank-sum tests. Data are the mean ± s.d. (a,b,d,e,i,m,n) or mean ± s.e.m. (k,o). The diagrams in c and j were created using BioRender (https://www.biorender.com). Source Data
Fig. 5 Targeting Tex-PSR chaperones prevents T cell exhaustion and enhances cancer immunotherapy. a, Frequencies of IFNγ+TNF+ cells (n = 3, one-way ANOVA) in cells with indicated genes knocked out. b, Quantification of protein aggregation by flow cytometry (n = 4, one-way ANOVA). c, Experimental scheme of using CD8+ T cell-specific deletion of Hsp90b1 in mice infected with LCMV clone 13. d, gp96 expression in total splenic CD8+ T cells (n = 8 for WT, n = 3 for Het, n = 5 for KO, one-way ANOVA). e, Frequencies of total CD8+ (left) and gp33-specific and gp276-specific (Tet+) CD8+ T cells (right) in spleens 30 days after infection (n = 8 for WT, n = 3 for Het, n = 5 for KO, one-way ANOVA). f, Uniform manifold approximation and projection (UMAP) of Tet+ CD8+ T cells profiled by 25-marker multispectral flow cytometry. g, Expression of selected markers mapped on UMAP. h,i, Representative flow cytometry (h) and quantification (i) of TCF1+CX3CR1–, CX3CR1+ and TCF1–CX3CR1– cells (n = 8 for WT, n = 3 for Het, n = 5 for KO, one-way ANOVA). j, Schematic of ACT using Hspa5 KO, Ero1a KO or control cells. k, Tumour growth curves (n = 4 for NT, n = 5 for the other groups, two-way ANOVA). l, Kaplan–Meier survival curves (n = 4 for NT, n = 5 for the other groups, Mantel–Cox test). Results represent three independent experiments. m,n, Representative flow cytometry plots (left) and quantification (right) of CX3CR1+ percentages (m) and TCF1 expression (n) in tumour-infiltrating P14 T cells 6 days after ACT (n = 8, two-tailed t-test). o, Tex-PSR scores in scRNA-seq CD8+ T cells from non-responders (NR) and responders (R) to anti-CD19 CAR T cell therapy for diffuse large B cell lymphoma61 (left, NR: n = 63,482 cells from 57 patients; R: n = 59,351 cells from 52 patients) and anti-PD1 therapy for non-small cell lung cancer62 and renal cell carcinoma (RCC)63 (right, NR: n = 5,672 cells from 6 patients, R: n = 37,884 cells from 18 patients). Two-sided Wilcoxon rank-sum tests. Data are the mean ± s.d. (a,b,d,e,i,m,n) or mean ± s.e.m. (k,o). The diagrams in c and j were created using BioRender (https://www.biorender.com). Source DataCC BY-NC-ND · PubMed Central
Extended Data Fig. 1 Study of the proteome changes during T cell exhaustion using an in vitro exhaustion model and quantitative mass spectrometry. a, Schematic diagram of generation of mouse CD8+ Tex cells in vitro by repetitive TCR stimulations followed by parallel bulk RNA-seq and mass spectrometry. b, Proliferation and viability of Teff and Tex cells during the 8-day course post initial activation (n = 4, two-way ANOVA). c, Representative flow cytometry plots and statistics of the percentage of PD-1+TIM-3+ (upper) and IFNγ+TNFα+ (bottom) cells over the total CD8+ T cells in Teff versus Tex cells (n = 3, two-tailed t test). d, Schematic diagram of the workflow of the chromatogram library-based data-independent acquisition (DIA) mass spectrometry. e, Expression levels of indicated proteins measured by flow cytometry (line) and mass spectrometry (scatter-bar). Teff cells were day 3 acutely activated CD8+ cells in vitro. Early and late Tex cells were day 3 and day 7 chronically activated CD8+ T cells. Data are presented as mean ± SD. Diagrams in a and d were created in BioRender. Wang, Y. (2025) https://BioRender.com/n0ibmgq. Source Data
Extended Data Fig. 1 Study of the proteome changes during T cell exhaustion using an in vitro exhaustion model and quantitative mass spectrometry. a, Schematic diagram of generation of mouse CD8+ Tex cells in vitro by repetitive TCR stimulations followed by parallel bulk RNA-seq and mass spectrometry. b, Proliferation and viability of Teff and Tex cells during the 8-day course post initial activation (n = 4, two-way ANOVA). c, Representative flow cytometry plots and statistics of the percentage of PD-1+TIM-3+ (upper) and IFNγ+TNFα+ (bottom) cells over the total CD8+ T cells in Teff versus Tex cells (n = 3, two-tailed t test). d, Schematic diagram of the workflow of the chromatogram library-based data-independent acquisition (DIA) mass spectrometry. e, Expression levels of indicated proteins measured by flow cytometry (line) and mass spectrometry (scatter-bar). Teff cells were day 3 acutely activated CD8+ cells in vitro. Early and late Tex cells were day 3 and day 7 chronically activated CD8+ T cells. Data are presented as mean ± SD. Diagrams in a and d were created in BioRender. Wang, Y. (2025) https://BioRender.com/n0ibmgq. Source DataCC BY-NC-ND · PubMed Central
Extended Data Fig. 2 Association as well as discordance between RNA and protein expression level in T cells. a, Correlation of RNA and protein expression levels of all detected molecules in Teff and Tex cells 8 days post initial activation. Each dot represents one molecule. A regression line with a shaded 95% confidence interval is shown. (r: Pearson correlation coefficient). b-c, Correlation between RNA levels and protein expression fold changes of molecules across one customer gene set and seven different gene ontologies between Tex and Teff cells (r: Pearson correlation coefficient; n: numbers of proteins/genes mapped to each gene ontology, A regression line with a shaded 95% confidence interval is shown). d, Bar plots of protein and mRNA expression changes of selected transcription factors in Tex vs Teff cells. e, Bar plots of protein and RNA expression changes of molecules belonging to the indicated gene ontologies in Tex vs. Teff cells.
Extended Data Fig. 2 Association as well as discordance between RNA and protein expression level in T cells. a, Correlation of RNA and protein expression levels of all detected molecules in Teff and Tex cells 8 days post initial activation. Each dot represents one molecule. A regression line with a shaded 95% confidence interval is shown. (r: Pearson correlation coefficient). b-c, Correlation between RNA levels and protein expression fold changes of molecules across one customer gene set and seven different gene ontologies between Tex and Teff cells (r: Pearson correlation coefficient; n: numbers of proteins/genes mapped to each gene ontology, A regression line with a shaded 95% confidence interval is shown). d, Bar plots of protein and mRNA expression changes of selected transcription factors in Tex vs Teff cells. e, Bar plots of protein and RNA expression changes of molecules belonging to the indicated gene ontologies in Tex vs. Teff cells.CC BY-NC-ND · PubMed Central
Extended Data Fig. 3 Study of T cell exhausion using an antigen-specific system against LCMV. a, Gating strategies for sorting antigen-specific CD8+ T cells into different subpopulations from the spleens of LCMV infected mice. Tet, tetramer. b, Heatmap of expression levels of 17 gene signatures in gp33+ T cell subpopulations on day 30 post LCMV Clone 13 infection (the scRNA-seq data were from Zander et al.). Tprog, Tint, Ttex subpopulations were determined based on their expression level of Slamf6 and Cx3cr1. c, Schematic diagram of longitudinal proteome analysis of P14 T cells transferred to mice and harvested 8, 15 and 30 days after infection with LCMV Armstrong or Clone 13. Created in BioRender. Wang, Y. (2025) https://BioRender.com/n0ibmgq. d, Heatmap of expression levels of proteins belonging to different T cell signatures in P14 T cells from LCMV Armstrong or Clone 13 infected mice. e, Expression dynamics of protein chaperones in P14 cells analyzed as in c (n = 4, two-tailed t test). Data are presented as box plots displaying the median (center line), 25th and 75th percentiles (bounds of the box), and minimum and maximum values (whiskers).
Extended Data Fig. 3 Study of T cell exhausion using an antigen-specific system against LCMV. a, Gating strategies for sorting antigen-specific CD8+ T cells into different subpopulations from the spleens of LCMV infected mice. Tet, tetramer. b, Heatmap of expression levels of 17 gene signatures in gp33+ T cell subpopulations on day 30 post LCMV Clone 13 infection (the scRNA-seq data were from Zander et al.). Tprog, Tint, Ttex subpopulations were determined based on their expression level of Slamf6 and Cx3cr1. c, Schematic diagram of longitudinal proteome analysis of P14 T cells transferred to mice and harvested 8, 15 and 30 days after infection with LCMV Armstrong or Clone 13. Created in BioRender. Wang, Y. (2025) https://BioRender.com/n0ibmgq. d, Heatmap of expression levels of proteins belonging to different T cell signatures in P14 T cells from LCMV Armstrong or Clone 13 infected mice. e, Expression dynamics of protein chaperones in P14 cells analyzed as in c (n = 4, two-tailed t test). Data are presented as box plots displaying the median (center line), 25th and 75th percentiles (bounds of the box), and minimum and maximum values (whiskers).CC BY-NC-ND · PubMed Central
Extended Data Fig. 4 Mass spectrometry-based quantitative proteomics uncovers proteome changes during T cell exhaustion. a, Bubble plot of the expressions of proteins associated with T cell stemness, activation and exhaustion. Bubble color intensity is proportional to protein expression level. Bubble size is proportional to the absolute z-score value. b, Enrichment analysis of proteins in cluster 1–5 and 7, 8 by Enrichr (one-sided Fisher’s exact test with Benjamini–Hochberg correction). Cluster 6 data was show in main Fig. 1. Top 10 significant gene ontologies are shown. c, PCA analysis of the proteome of in vitro-generated Teff and Tex cells at indicated time points. d, Schematic diagram of generating Teff, early and late Tex in vitro. Created in BioRender. Wang, Y. (2025) https://BioRender.com/n0ibmgq. e, Gene set enrichment analysis of differentially expressed proteins in early Tex versus Teff (top) and late Tex versus Teff cells (bottom). f, Volcano plots of differentially expressed proteins in late Tex versus Teff cells (two-sided t-tests with Benjamini–Hochberg correction). Proteins belonging to GO term “Responses to ER stress” are colored.
Extended Data Fig. 4 Mass spectrometry-based quantitative proteomics uncovers proteome changes during T cell exhaustion. a, Bubble plot of the expressions of proteins associated with T cell stemness, activation and exhaustion. Bubble color intensity is proportional to protein expression level. Bubble size is proportional to the absolute z-score value. b, Enrichment analysis of proteins in cluster 1–5 and 7, 8 by Enrichr (one-sided Fisher’s exact test with Benjamini–Hochberg correction). Cluster 6 data was show in main Fig. 1. Top 10 significant gene ontologies are shown. c, PCA analysis of the proteome of in vitro-generated Teff and Tex cells at indicated time points. d, Schematic diagram of generating Teff, early and late Tex in vitro. Created in BioRender. Wang, Y. (2025) https://BioRender.com/n0ibmgq. e, Gene set enrichment analysis of differentially expressed proteins in early Tex versus Teff (top) and late Tex versus Teff cells (bottom). f, Volcano plots of differentially expressed proteins in late Tex versus Teff cells (two-sided t-tests with Benjamini–Hochberg correction). Proteins belonging to GO term “Responses to ER stress” are colored.CC BY-NC-ND · PubMed Central
Extended Data Fig. 5 Exhausted T cells do not have expected features of translational attenuation. a, Bar plot of protein and RNA expression changes of IRES motif-containing genes in Tex vs Teff cells 8 days post initial activation from the in vitro exhaustion model. b, Correlations of RNA and protein expression fold changes of EIF2A-dependent and EIF2A-independent genes in Tex vs Teff cells. A regression line with a shaded 95% confidence interval is shown. c, Enrichment analysis by Enrichr on proteins showing upregulation in both RNA and protein level (circled, left) in Tex versus Teff cells (one-sided Fisher’s exact test with Benjamini–Hochberg correction). A regression line with a shaded 95% confidence interval is shown in the left panel. d, PDCD4 expression across different CD8+ T cells subpopulations from in vitro exhaustion and in vivo tumor models by mass spectrometry (n = 5 for in vitro model, n = 3 for MC38 and MB49 tumor models, one-way ANOVA). Data are presented as mean (center line) and min to max (box bounds). e, The left panel is the heatmap of protein expression levels associated with selected Gene Ontology (GO) terms in in vitro-generated Teff and Tex cells 8 days post initial activation. Gene Set Enrichment Analysis (GSEA, right) compares Tex versus Teff cells, with normalized enrichment score (NES), gene rank distribution, and associated unadjusted P values are shown. P values were estimated using an adaptive multi-level split Monte Carlo scheme. f, Volcano plots of differentially expressed proteins in Tex versus Teff cells. Red: translation-related proteins; Blue: transcription-related proteins; Grey: other proteins (two-sided t-tests with Benjamini–Hochberg correction). g, Mass spectrometry analysis of protein expression levels of RPL13, eIF4E and eEF2 (n = 3 for Teff and n = 4 for Tex, two-tailed t test). Source Data
Extended Data Fig. 5 Exhausted T cells do not have expected features of translational attenuation. a, Bar plot of protein and RNA expression changes of IRES motif-containing genes in Tex vs Teff cells 8 days post initial activation from the in vitro exhaustion model. b, Correlations of RNA and protein expression fold changes of EIF2A-dependent and EIF2A-independent genes in Tex vs Teff cells. A regression line with a shaded 95% confidence interval is shown. c, Enrichment analysis by Enrichr on proteins showing upregulation in both RNA and protein level (circled, left) in Tex versus Teff cells (one-sided Fisher’s exact test with Benjamini–Hochberg correction). A regression line with a shaded 95% confidence interval is shown in the left panel. d, PDCD4 expression across different CD8+ T cells subpopulations from in vitro exhaustion and in vivo tumor models by mass spectrometry (n = 5 for in vitro model, n = 3 for MC38 and MB49 tumor models, one-way ANOVA). Data are presented as mean (center line) and min to max (box bounds). e, The left panel is the heatmap of protein expression levels associated with selected Gene Ontology (GO) terms in in vitro-generated Teff and Tex cells 8 days post initial activation. Gene Set Enrichment Analysis (GSEA, right) compares Tex versus Teff cells, with normalized enrichment score (NES), gene rank distribution, and associated unadjusted P values are shown. P values were estimated using an adaptive multi-level split Monte Carlo scheme. f, Volcano plots of differentially expressed proteins in Tex versus Teff cells. Red: translation-related proteins; Blue: transcription-related proteins; Grey: other proteins (two-sided t-tests with Benjamini–Hochberg correction). g, Mass spectrometry analysis of protein expression levels of RPL13, eIF4E and eEF2 (n = 3 for Teff and n = 4 for Tex, two-tailed t test). Source DataCC BY-NC-ND · PubMed Central
Extended Data Fig. 6 Protein synthesis is upregulated in exhausted T cells in both tumor and chronic LCMV infection models. a, Volcano plots of differentially expressed proteins in P14 T cells from LCMV acute and chronic infections as described in Extended Data Fig. 3c. Proteins belonging to the protein translation (GO:0006412) are colored in red. b, eIF2D and eIF4G3 expression in P14 T cells from LCMV acute and chronic infections (n = 4, multiple t test). Data are presented as box plots displaying the median (center line), 25th and 75th percentiles (bounds of the box), and minimum and maximum values (whiskers). c-d, Flow cytometry histogram and bar plot of 30-min HPG incorporation ex vivo in tumor-infiltrating CD8+ T cell subpopulations from mouse MC38 (c) and MB49 (d) tumors (spleen: n = 4, TIL: n = 7, one-way ANOVA). Data in c and d are presented as mean ± SD. Source Data
Extended Data Fig. 6 Protein synthesis is upregulated in exhausted T cells in both tumor and chronic LCMV infection models. a, Volcano plots of differentially expressed proteins in P14 T cells from LCMV acute and chronic infections as described in Extended Data Fig. 3c. Proteins belonging to the protein translation (GO:0006412) are colored in red. b, eIF2D and eIF4G3 expression in P14 T cells from LCMV acute and chronic infections (n = 4, multiple t test). Data are presented as box plots displaying the median (center line), 25th and 75th percentiles (bounds of the box), and minimum and maximum values (whiskers). c-d, Flow cytometry histogram and bar plot of 30-min HPG incorporation ex vivo in tumor-infiltrating CD8+ T cell subpopulations from mouse MC38 (c) and MB49 (d) tumors (spleen: n = 4, TIL: n = 7, one-way ANOVA). Data in c and d are presented as mean ± SD. Source DataCC BY-NC-ND · PubMed Central
Extended Data Fig. 7 Stress granules, proteasomal and lysosomal activities are increased in Tex cells. All experiments were performed using mouse Teff and Tex cells generated in vitro 8 days post initial activation. a, ImageStream analysis of G3BP1 stress granules (SGs) in Teff and Tex cells. b, Quantification of the frequency of G3BP1 SGs in Teff and Tex cells determined with Bright Detail Intensity by ImageStream analysis. At least 2,000 live cells were examined for each replicate (n = 4, two-tailed t test). c, Flow cytometry quantification of G3BP1 expression in Teff and Tex cells (n = 4, two-tailed t test). d, Representative flow cytometry plots and statistics of G3BP1 expression in G3bp1 knockout and control wild-type Tex cells (n = 4, two-tailed t test). e, Representative flow cytometry plots and statistics of the percentage of IFNγ+TNFα+ cells out of the total CD8+ T cells in G3bp1 knockout and wild-type Tex cells (n = 4, two-tailed t test). f, Viability of G3bp1 knockout and wild-type Tex cells (n = 4, two-tailed t test). g, Proteasomal activity in Teff and Tex cells (n = 4, two-tailed t test). h, Flow cytometry quantification of lysosome mass in Teff and Tex cells (n = 6, two-tailed t test). i, Degradation kinetics of newly synthesized proteins in Teff and Tex cells (n = 3). j, Fold changes of HPG MFI 8 h post “pulsing” with MG132, Bafilomycin A1(BafA1) or DMSO in Tex cells (n = 5, one-way ANOVA). Data in b-h and j are presented as mean ± SD. Data in i are presented as mean ± SEM. Source Data
Extended Data Fig. 7 Stress granules, proteasomal and lysosomal activities are increased in Tex cells. All experiments were performed using mouse Teff and Tex cells generated in vitro 8 days post initial activation. a, ImageStream analysis of G3BP1 stress granules (SGs) in Teff and Tex cells. b, Quantification of the frequency of G3BP1 SGs in Teff and Tex cells determined with Bright Detail Intensity by ImageStream analysis. At least 2,000 live cells were examined for each replicate (n = 4, two-tailed t test). c, Flow cytometry quantification of G3BP1 expression in Teff and Tex cells (n = 4, two-tailed t test). d, Representative flow cytometry plots and statistics of G3BP1 expression in G3bp1 knockout and control wild-type Tex cells (n = 4, two-tailed t test). e, Representative flow cytometry plots and statistics of the percentage of IFNγ+TNFα+ cells out of the total CD8+ T cells in G3bp1 knockout and wild-type Tex cells (n = 4, two-tailed t test). f, Viability of G3bp1 knockout and wild-type Tex cells (n = 4, two-tailed t test). g, Proteasomal activity in Teff and Tex cells (n = 4, two-tailed t test). h, Flow cytometry quantification of lysosome mass in Teff and Tex cells (n = 6, two-tailed t test). i, Degradation kinetics of newly synthesized proteins in Teff and Tex cells (n = 3). j, Fold changes of HPG MFI 8 h post “pulsing” with MG132, Bafilomycin A1(BafA1) or DMSO in Tex cells (n = 5, one-way ANOVA). Data in b-h and j are presented as mean ± SD. Data in i are presented as mean ± SEM. Source DataCC BY-NC-ND · PubMed Central
Extended Data Fig. 8 Effector molecule granzyme B but not inhibitory receptor PD-1 is enriched in insoluble aggregates of Tex cells. a, Schematic diagram of fractionate soluble and insoluble proteins in the cell lysates of Teff and Tex cells 8 days post initial activation in vitro for mass spectrometry analysis. Created in BioRender. Wang, Y. (2025) https://BioRender.com/n0ibmgq. b, Representative chromatograms of the retention time and intensity for peptides indicative of granzyme B in insoluble and soluble protein. Raw intensity is on the y-axis and retention time in minutes is on the x-axis. Each colored line represents a fragment ion associated with the peptide for granzyme B. Solid lines indicate fragment ions used for quantitation. Dotted lines represent interfering ions that were excluded for quantitation. The plot on the far right showed the fold change of granzyme B in the insoluble over soluble fractions in Tex and Teff cells. ΔΔ: Tex[Log2FC(insoluble/soluble)] - Teff[Log2FC(insoluble/soluble)]. c, Representative chromatograms of the retention time and intensity for peptides indicative of PD-1 in the insoluble and soluble fractions. The fold changes of PD-1 in the insoluble over soluble fractions in Tex and Teff cells are also shown.
Extended Data Fig. 8 Effector molecule granzyme B but not inhibitory receptor PD-1 is enriched in insoluble aggregates of Tex cells. a, Schematic diagram of fractionate soluble and insoluble proteins in the cell lysates of Teff and Tex cells 8 days post initial activation in vitro for mass spectrometry analysis. Created in BioRender. Wang, Y. (2025) https://BioRender.com/n0ibmgq. b, Representative chromatograms of the retention time and intensity for peptides indicative of granzyme B in insoluble and soluble protein. Raw intensity is on the y-axis and retention time in minutes is on the x-axis. Each colored line represents a fragment ion associated with the peptide for granzyme B. Solid lines indicate fragment ions used for quantitation. Dotted lines represent interfering ions that were excluded for quantitation. The plot on the far right showed the fold change of granzyme B in the insoluble over soluble fractions in Tex and Teff cells. ΔΔ: Tex[Log2FC(insoluble/soluble)] - Teff[Log2FC(insoluble/soluble)]. c, Representative chromatograms of the retention time and intensity for peptides indicative of PD-1 in the insoluble and soluble fractions. The fold changes of PD-1 in the insoluble over soluble fractions in Tex and Teff cells are also shown.CC BY-NC-ND · PubMed Central
Extended Data Fig. 9 Moderate attenuation of Akt signaling but not PI3K and mTOR pathways prevents T cell exhaustion without compromising cell survival and proliferation. Mouse CD8+ T cells were first activated in vitro for 48 h, followed by chronic TCR stimulation in the presence of various pharmacological inhibitors and the final downstream analysis. a-f, Representative flow cytometry plots and statistics of the percentages of live cells (a), Ki67+ population (b), SLAMF6+TIM-3- population (c), IFNγ+TNFα+ population (d), CD44+CD62L+ population (e) and CD107a production (f). For measuring cytokine production (IFNγ, TNFα and CD107a), cells were rested for two additional days after 6-day treatment and restimulated with PMA/Ionomycin (n = 4, one-way ANOVA). Data in a -f are presented as mean ± SD. Source Data
Extended Data Fig. 9 Moderate attenuation of Akt signaling but not PI3K and mTOR pathways prevents T cell exhaustion without compromising cell survival and proliferation. Mouse CD8+ T cells were first activated in vitro for 48 h, followed by chronic TCR stimulation in the presence of various pharmacological inhibitors and the final downstream analysis. a-f, Representative flow cytometry plots and statistics of the percentages of live cells (a), Ki67+ population (b), SLAMF6+TIM-3- population (c), IFNγ+TNFα+ population (d), CD44+CD62L+ population (e) and CD107a production (f). For measuring cytokine production (IFNγ, TNFα and CD107a), cells were rested for two additional days after 6-day treatment and restimulated with PMA/Ionomycin (n = 4, one-way ANOVA). Data in a -f are presented as mean ± SD. Source DataCC BY-NC-ND · PubMed Central
Extended Data Fig. 10 Impact of deletion of TexPSR chaperones on T cell exhaustion. Experiments were performed using in vitro exhausted T cells (a-g) and LCMV model in vivo (h). a, Expressions of the 10 candidate proteins in T cell exhaustion across 4 differentiation states as described in Extended Data Fig. 4d by mass spectrometry (n = 5, one-way ANOVA). Data are presented as mean (center line) and min to max (box bounds). b, Confirmation of CRISPR knockout of respective genes by RT-PCR. c, Confirmation of CRISPR knockout of indicated genes at the protein level by flow cytometry. d, Bar plot of the percentage of IFNγ+TNFα+ cells out of the total CD8+ T cells 8 days post CRISPR-Cas9 knockout of indicated genes and chronic stimulation (n = 3, experiment was repeated three times). e, Representative flow cytometry plot and percentages of SLAMF6-TIM-3+ population over total live CD8+ T cells after Hspa5, Ero1a or Hsp90b1 knockout or control (n = 3, one-way ANOVA). f, UMAP visualization of Tex cells with Hspa5, Ero1a or Hsp90b1 knockout or control T cells analyzed with 26 markers associated with T cell activation and exhaustion indicated in g by multi-spectral flow cytometry. g, Heatmap of expression pattern of 26 markers across 12 cell clusters. Data was shown using all concatenated cells. h, gp96 expression in different Tex subsets gated on CD44+PD-1+ CD8+ T cells from day 30 LCMV Clone 13 infected wild type mouse spleens. Naïve CD8+ T cells were CD44-CD8+ T cells from uninfected mice (n = 5 for naïve CD8+, n = 10 for Tprog, Tint and Ttex, one-way ANOVA). Data in b-e and h are presented as mean ± SD. Source Data
Extended Data Fig. 10 Impact of deletion of TexPSR chaperones on T cell exhaustion. Experiments were performed using in vitro exhausted T cells (a-g) and LCMV model in vivo (h). a, Expressions of the 10 candidate proteins in T cell exhaustion across 4 differentiation states as described in Extended Data Fig. 4d by mass spectrometry (n = 5, one-way ANOVA). Data are presented as mean (center line) and min to max (box bounds). b, Confirmation of CRISPR knockout of respective genes by RT-PCR. c, Confirmation of CRISPR knockout of indicated genes at the protein level by flow cytometry. d, Bar plot of the percentage of IFNγ+TNFα+ cells out of the total CD8+ T cells 8 days post CRISPR-Cas9 knockout of indicated genes and chronic stimulation (n = 3, experiment was repeated three times). e, Representative flow cytometry plot and percentages of SLAMF6-TIM-3+ population over total live CD8+ T cells after Hspa5, Ero1a or Hsp90b1 knockout or control (n = 3, one-way ANOVA). f, UMAP visualization of Tex cells with Hspa5, Ero1a or Hsp90b1 knockout or control T cells analyzed with 26 markers associated with T cell activation and exhaustion indicated in g by multi-spectral flow cytometry. g, Heatmap of expression pattern of 26 markers across 12 cell clusters. Data was shown using all concatenated cells. h, gp96 expression in different Tex subsets gated on CD44+PD-1+ CD8+ T cells from day 30 LCMV Clone 13 infected wild type mouse spleens. Naïve CD8+ T cells were CD44-CD8+ T cells from uninfected mice (n = 5 for naïve CD8+, n = 10 for Tprog, Tint and Ttex, one-way ANOVA). Data in b-e and h are presented as mean ± SD. Source DataCC BY-NC-ND · PubMed Central
Extended Data Fig. 11 Patients with high TexPSR signature in tumor-infiltrating T cells do poorly in response to immunotherapy. a, Overview of CD8+ T cell counts and subtype distributions across different cancer types from integrated analysis of publicly available pan-cancer scRNA-seq datasets. Left panel: total number of CD8+ T cells detected in each cancer type, plotted on a logarithmic scale. Middle left panel: sample counts in each cancer type, plotted on a logarithmic scale. Middle right panel: number of independent studies for each cancer type. Right panel: CD8+ T cell subtype proportion. BLCA: bladder urothelial carcinoma; BRCA: breast invasive carcinoma; CESC: cervical squamous cell carcinoma and endocervical adenocarcinoma; CHOL: cholangiocarcinoma; CRC: colorectal cancer; GIM: gastric and intestinal malignancies; HNSC: head and neck squamous cell carcinoma; LC: lung cancer; LIHC: liver hepatocellular carcinoma; OC: ovarian cancer; PAAD: pancreatic adenocarcinoma; PDAC: pancreatic ductal adenocarcinoma; PRAD: prostate adenocarcinoma; RCC/CRCC: renal cell carcinoma/clear cell renal cell carcinoma; STAD: stomach adenocarcinoma; THCA: thyroid carcinoma; UCEC: uterine corpus endometrial carcinoma. b, Heatmap showing the expression level of TexPSR signature genes across various T cell populations. c, Correlation of RNA and protein expression fold changes of TexPSR signature genes between Tex versus Teff cells from the in vitro exhaustion model. d, TexPSR signature scores across different T cell subpopulations (two-sided Wilcoxon rank sum test). e, UMAP embedding of scRNA-seq data from T cells colored by annotated cell types. Overlaid are RNA velocity-based trajectories, inferred with the Slingshot algorithm, delineating two major differentiation pathways: Trajectory 1 (teal) toward exhaustion and Trajectory 2 (orange) toward effector differentiation. f. Signature scores along pseudotime for each trajectory. Trajectory 1 (left) shows decreasing Naive and increasing Exhaustion and TexPSR scores, consistent with an exhaustion trajectory. Trajectory 2 (right) shows dynamic changes in TexPSR and Naive scores, indicative of an alternative effector trajectory. g, Kaplan-Meier survival curves for patients with liver cancer stratified by high vs. low TexPSR signature, calculated from the CD8+ T cell scRNAseq data. P values were calculated using a univariate Cox proportional hazards model. h, TexPSR scores in scRNA-seq datasets of CD8+ T cells from non-responders (NR) and responders (R) in response to αPD-1 combined with αCTLA-4 therapy for RCC (NR: n = 5354 cells from 6 patients, R: n = 15207 cells from 9 patients). Data are presented as mean ± SEM, and statistical significance was determined using two-sided Wilcoxon rank sum tests.
Extended Data Fig. 11 Patients with high TexPSR signature in tumor-infiltrating T cells do poorly in response to immunotherapy. a, Overview of CD8+ T cell counts and subtype distributions across different cancer types from integrated analysis of publicly available pan-cancer scRNA-seq datasets. Left panel: total number of CD8+ T cells detected in each cancer type, plotted on a logarithmic scale. Middle left panel: sample counts in each cancer type, plotted on a logarithmic scale. Middle right panel: number of independent studies for each cancer type. Right panel: CD8+ T cell subtype proportion. BLCA: bladder urothelial carcinoma; BRCA: breast invasive carcinoma; CESC: cervical squamous cell carcinoma and endocervical adenocarcinoma; CHOL: cholangiocarcinoma; CRC: colorectal cancer; GIM: gastric and intestinal malignancies; HNSC: head and neck squamous cell carcinoma; LC: lung cancer; LIHC: liver hepatocellular carcinoma; OC: ovarian cancer; PAAD: pancreatic adenocarcinoma; PDAC: pancreatic ductal adenocarcinoma; PRAD: prostate adenocarcinoma; RCC/CRCC: renal cell carcinoma/clear cell renal cell carcinoma; STAD: stomach adenocarcinoma; THCA: thyroid carcinoma; UCEC: uterine corpus endometrial carcinoma. b, Heatmap showing the expression level of TexPSR signature genes across various T cell populations. c, Correlation of RNA and protein expression fold changes of TexPSR signature genes between Tex versus Teff cells from the in vitro exhaustion model. d, TexPSR signature scores across different T cell subpopulations (two-sided Wilcoxon rank sum test). e, UMAP embedding of scRNA-seq data from T cells colored by annotated cell types. Overlaid are RNA velocity-based trajectories, inferred with the Slingshot algorithm, delineating two major differentiation pathways: Trajectory 1 (teal) toward exhaustion and Trajectory 2 (orange) toward effector differentiation. f. Signature scores along pseudotime for each trajectory. Trajectory 1 (left) shows decreasing Naive and increasing Exhaustion and TexPSR scores, consistent with an exhaustion trajectory. Trajectory 2 (right) shows dynamic changes in TexPSR and Naive scores, indicative of an alternative effector trajectory. g, Kaplan-Meier survival curves for patients with liver cancer stratified by high vs. low TexPSR signature, calculated from the CD8+ T cell scRNAseq data. P values were calculated using a univariate Cox proportional hazards model. h, TexPSR scores in scRNA-seq datasets of CD8+ T cells from non-responders (NR) and responders (R) in response to αPD-1 combined with αCTLA-4 therapy for RCC (NR: n = 5354 cells from 6 patients, R: n = 15207 cells from 9 patients). Data are presented as mean ± SEM, and statistical significance was determined using two-sided Wilcoxon rank sum tests.CC BY-NC-ND · PubMed Central
Extended Data Fig. 12 Working model of TexPSR as a mechanistic driver of CD8+ T cell exhaustion. The model presented illustrates a cancer cell at the top interacting with an exhausted T cell at the bottom through the MHC class I–T cell receptor complex. The intracellular events inside of the Tex cells underscore key novel findings from the study, which collectively elucidate a proteotoxic stress response (PSR) driving T cell exhaustion, a phenomenon we term TexPSR. TexPSR is characterized by an elevated rate of protein synthesis, the accumulation of intracellular protein aggregates, the upregulation of specific endoplasmic reticulum (ER) chaperones, and an accelerated protein catabolism pathway. Central to these processes is the sustained activation of AKT signaling, which orchestrates this complex proteotoxic environment. These findings not only provide deeper insight into the molecular mechanisms of T cell dysfunction within the tumor microenvironment but also open avenues for possible therapeutic strategies aimed at mitigating TexPSR to restore immune cell function in cancer immunotherapy. The figure was reproduced with the permission of The Ohio State University.
Extended Data Fig. 12 Working model of TexPSR as a mechanistic driver of CD8+ T cell exhaustion. The model presented illustrates a cancer cell at the top interacting with an exhausted T cell at the bottom through the MHC class I–T cell receptor complex. The intracellular events inside of the Tex cells underscore key novel findings from the study, which collectively elucidate a proteotoxic stress response (PSR) driving T cell exhaustion, a phenomenon we term TexPSR. TexPSR is characterized by an elevated rate of protein synthesis, the accumulation of intracellular protein aggregates, the upregulation of specific endoplasmic reticulum (ER) chaperones, and an accelerated protein catabolism pathway. Central to these processes is the sustained activation of AKT signaling, which orchestrates this complex proteotoxic environment. These findings not only provide deeper insight into the molecular mechanisms of T cell dysfunction within the tumor microenvironment but also open avenues for possible therapeutic strategies aimed at mitigating TexPSR to restore immune cell function in cancer immunotherapy. The figure was reproduced with the permission of The Ohio State University.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

16 Valid · 0 Not valid · 1 Not checked · 125 Own results and interpretations

84 more claims

Create a free account to see all 142 claims and to verify the 3 references still open.

See all claims — free account
  • It may state two separate claims as one. 32
  • Probably not a substantial claim. 22

Create a free account to see these claims.

Citations

Cites

Show all 110 references

Cited by

See all 68

Metadata

Authors
Wang, Y., Ma, A., Song, N.-J., Shannon, A. E., Amankwah, Y. S., Chen, X., Wu, W., Wang, Z., Saadey, A. A., Yousif, A., Ghosh, G., Mandula, J. K., Velegraki, M., Xiao, T., Wen, H., Huang, S. C.-C., Wang, R., Beusch, C. M., Dawood, A. S., Gordon, D. E., Abdel-Hakeem, M. S., Ghoneim, H. E., Xin, G., Searle, B. C., & Li, Z.
Affiliations
  • The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
  • Johns Hopkins University (US)
  • The Ohio State University (US)
  • Nationwide Children's Hospital (US)
  • Uppsala University (SE)
  • Emory University (US)
Corresponding author
Li, Zihai
Venue
Nature
Published
2025-10-01
Volume
647
Issue
8091
Pages
1025-1035
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4414690652
Cited by
68
References
110
Citations by year
2026: 61 · 2025: 7
FWCI
27.93
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Diva portal (Dalarna University Library) (submittedVersion, other-oa)
Funders
  • National Cancer Institute (R21CA267394, R01CA247941, P30CA016058, P01CA278732, R01CA282501, R01CA262069)
  • National Institute of General Medical Sciences (R35GM150723)
  • National Institute of Allergy and Infectious Diseases (R01AI114581, R01AI170926)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
Keywords
T cell exhaustion, proteostasis, CD8+ T cells, mRNA translation, molecular chaperones, stress granules, protein aggregates, autophagy, Akt signaling, chronic viral infection, cancer immunotherapy, proteome
MeSH terms
Proteostasis, Stress Granules, T-Cell Exhaustion, Proteotoxic Stress, Animals, Autophagy, Female, Humans, Male, Mice, Inbred C57BL, RNA, Messenger, Stress, Physiological, Protein Biosynthesis, CD8-Positive T-Lymphocytes, Proteome, Mice, Immune Evasion

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Proteotoxic stress response drives T cell exhaustion and immune evasion. https://app.cochat.ai/papers/10.1038/s41586-025-09539-1
The paper
Wang, Y., Ma, A., Song, N.-J., Shannon, A. E., Amankwah, Y. S., Chen, X., Wu, W., Wang, Z., Saadey, A. A., Yousif, A., Ghosh, G., Mandula, J. K., Velegraki, M., Xiao, T., Wen, H., Huang, S. C.-C., Wang, R., Beusch, C. M., Dawood, A. S., . . . Li, Z. (2025). Proteotoxic stress response drives T cell exhaustion and immune evasion. Nature. https://doi.org/10.1038/s41586-025-09539-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.